| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | | Total Revenue | 157,502 | 121,499 | | Cost of Revenue | 102,924 | 84,871 | | | Gross Profit | 54,578 | 36,628 | | | Operating Expenses | | Research Development | 8,829 | 1,857 | | Selling General and Administrative | 53,059 | 36,222 | | Non Recurring |
-
| 47 | | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (7,311) | (1,499) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,661 | 8,051 | | Earnings Before Interest And Taxes | (4,649) | 6,553 | | Interest Expense | 954 | 4,304 | | Income Before Tax | (5,603) | 2,248 | | Income Tax Expense | 3,061 | 1,092 | | Minority Interest | (5,187) | (2,833) | | | | Net Income From Continuing Ops | (13,851) | (1,677) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (13,851) | (1,677) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($13,851) | ($1,677) |
|
1.52% Nasdaq 
Income Statement
